Long-Term Assets: The sum of all assets classified as non-current.
Senti Biosciences, Inc. (SNTI) had Long-Term Assets of $27.95M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.02M |
|
$-61.44M |
|
-- |
|
$0.02M |
|
$68.80M |
|
$-68.78M |
|
$7.34M |
|
$-61.44M |
|
$-61.44M |
|
$-61.44M |
|
$-61.44M |
|
$-61.44M |
|
$-61.44M |
|
$-68.78M |
|
$-65.14M |
|
22.48M |
|
22.48M |
|
$-2.73 |
|
$-2.73 |
|
| Balance Sheet Financials | |
$23.27M |
|
$12.89M |
|
|
Long-Term Assets |
$27.95M |
$51.22M |
|
$13.97M |
|
-- |
|
$31.66M |
|
$45.63M |
|
$5.59M |
|
$5.59M |
|
$5.59M |
|
30.88M |
|
| Cash Flow Statement Financials | |
$-43.44M |
|
$-0.18M |
|
$11.76M |
|
$51.81M |
|
$19.95M |
|
$-31.87M |
|
$5.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-312631.80% |
|
-312631.80% |
|
-296100.00% |
|
-279263.70% |
|
-279263.70% |
|
$-43.63M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.01 |
|
0.03M |
|
-1099.27% |
|
-1099.27% |
|
-119.94% |
|
-1099.27% |
|
$0.18 |
|
$-1.94 |
|
$-1.93 |
|